热门话题-Replimune和uniQure股价上涨;FDA局长马卡里计划辞职

路透中文
May 13
热门话题-Replimune和uniQure股价上涨;FDA局长马卡里计划辞职

5月12日 - ** 生物技术公司Replimune Group(REPL.O)股价上涨14.7%,至4.2美元

** 据两位知情人士透露,美国食品和药物管理局(FDA)局长马卡里(Marty Makary)计划于周二辞职 (link)

** 最先报道这一消息的《政客》网站称,FDA副局长迪亚曼塔斯(Kyle Diamantas)将代理该机构负责人职务

** 上月,该卫生监管机构第二次拒绝批准 (link) REPL的药物

** 荷兰基因疗法开发商uniQure(UQ1.F)在美上市的股票上涨6.1%,报29.4美元

** 美国食品药品监督管理局(FDA)今年3月曾要求开展一项新研究 (link),以支持uniQure针对一种罕见遗传性神经退行性疾病的基因疗法获得批准,并因其最新试验未纳入接受安慰剂的受试者而予以驳回

** 包括辉瑞PFE.N)和莫德纳(MRNA.O)在内的疫苗制造商股价均上涨逾1%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10